| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $117K | -42.5% |
| Cost of Revenue | $99K | -89.7% |
| Gross Profit | $18K | +102.4% |
| R&D Expense | $187K | -36.4% |
| SG&A Expense | $269K | -8.8% |
| Operating Income | -$794K | +55.2% |
| Pre-tax Income | -$1.1M | +39.4% |
| Net Income | -$1.1M | +39.4% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $463K | -35.6% |
| Accounts Receivable | $3K | -69.6% |
| Inventory | $99K | +0.0% |
| Current Assets | $492K | -41.2% |
| Total Assets | $592K | -51.0% |
| Current Liabilities | $255K | +9.9% |
| Total Liabilities | $255K | -7.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$683K | +13.7% |
| Capital Expenditures | $125K | -15.5% |
| Investing Cash Flow | -$125K | +15.5% |
| Financing Cash Flow | $552K | +400.1% |
| Free Cash Flow | -$808K | +14.0% |
| — |
| EPS (Diluted) | $0.00 | — |
| Stockholders' Equity |
| $337K |
| -63.8% |